Neurobiology of Aging
Volume 30, Issue 5 , Pages 697-716 , May 2009

Age-related accumulation of Reelin in amyloid-like deposits

  • Irene Knuesel

      Affiliations

    • Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 635 55 97; fax: +41 44 635 68 74.
    • ,
  • Myriel Nyffeler

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • ,
  • Cecile Mormède

      Affiliations

    • Laboratory of Cognitive Neurosciences, UMR5106, University of Bordeaux 1, Talence Cedex, France
    • ,
  • Mary Muhia

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • ,
  • Urs Meyer

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • ,
  • Susanna Pietropaolo

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • ,
  • Benjamin K. Yee

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • ,
  • Christopher R. Pryce

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland
    • Present address: NOVARTIS Pharma AG, Basel, Switzerland.
    • ,
  • Frank M. LaFerla

      Affiliations

    • Department of Neurobiology and Behaviour, University of California, Irvine, USA
    • ,
  • Aline Marighetto

      Affiliations

    • Laboratory of Cognitive Neurosciences, UMR5106, University of Bordeaux 1, Talence Cedex, France
    • ,
  • Joram Feldon

      Affiliations

    • Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzenbach, Switzerland

Received 26 February 2007 ,Revised 23 July 2007 ,Accepted 13 August 2007.

References 

  1. Abraham H, Meyer G. Reelin-expressing neurons in the postnatal and adult human hippocampal formation. Hippocampus. 2003;13:715–727
  2. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol. Aging. 2000;21:383–421
  3. Akiyama H, Kameyama M, Akiguchi I, Sugiyama H, Kawamata T, Fukuyama H, et al. Periodic acid-Schiff (PAS)-positive, granular structures increase in the brain of senescence accelerated mouse (SAM). Acta Neuropathol. (Berl). 1986;72:124–129
  4. Alcantara S, Ruiz M, D’Arcangelo G, Ezan F, de Lecea L, Curran T, et al. Regional and cellular patterns of Reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 1998;18:7779–7799
  5. Arnaud L, Ballif BA, Cooper JA. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol. Cell. Biol. 2003;23:9293–9302
  6. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Multiple cognitive deficits during the transition to Alzheimer's disease. J. Intern. Med. 2004;256:195–204
  7. Baloyannis SJ. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study. Int. J. Neurosci. 2005;115:965–980
  8. Beffert U, Durudas A, Weeber EJ, Stolt PC, Giehl KM, Sweatt JD, et al. Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci. 2006;26:2041–2052
  9. Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, et al. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron. 2005;47:567–579
  10. Beffert U, Weeber EJ, Morfini G, Ko J, Brady ST, Tsai LH, et al. Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J. Neurosci. 2004;24:1897–1906
  11. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675–688
  12. Bock HH, Jossin Y, May P, Bergner O, Herz J. Apolipoprotein E receptors are required for Reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J. Biol. Chem. 2004;279:33471–33479
  13. Botella-Lopez A, Burgaya F, Gavin R, Garcia-Ayllon MS, Gomez-Tortosa E, Pena-Casanova J, et al. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006;103:5573–5578
  14. Chen Y, Beffert U, Ertunc M, Tang TS, Kavalali ET, Bezprozvanny I, et al. Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci. 2005;25:8209–8216
  15. Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, et al. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 2007;27:2727–2733
  16. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci. Biobehav. Rev. 2000;24:365–374
  17. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923
  18. D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T. Reelin is a ligand for lipoprotein receptors. Neuron. 1999;24:471–479
  19. D’Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995;374:719–723
  20. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus. 1996;6:347–470
  21. Fritschy JM, Weinmann O, Wenzel A, Benke D. Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J. Comp. Neurol. 1998;390:194–210
  22. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984;120:885–890
  23. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 1986;83:4913–4917
  24. Herz J, Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 2006;7:850–859
  25. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron. 1999;24:481–489
  26. Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW. FE65 interaction with the ApoE receptor ApoEr2. J. Biol. Chem. 2006;281:24521–24530
  27. Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW. Dab1 and Reelin effects on APP and ApoEr2 trafficking and processing. J. Biol. Chem. 2006;281:35176–35185
  28. Howell BW, Hawkes R, Soriano P, Cooper JA. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature. 1997;389:733–737
  29. Jucker M, Walker LC, Kuo H, Tian M, Ingram DK. Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity. Mol. Neurobiol. 1994;9:125–133
  30. Jucker M, Walker LC, Schwarb P, Hengemihle J, Kuo H, Snow AD, et al. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience. 1994;60:875–889
  31. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486–489
  32. Kim JH, Lee HK, Takamiya K, Huganir RL. The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J. Neurosci. 2003;23:1119–1124
  33. Knuesel I, Elliott A, Chen HJ, Mansuy IM, Kennedy MB. A role for synGAP in regulating neuronal apoptosis. Eur. J. Neurosci. 2005;21:611–621
  34. Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, et al. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 2002;22:9721–9732
  35. Lamar CH, Hinsman EJ, Henrikson CK. Alterations in the hippocampus of aged mice. Acta Neuropathol. (Berl). 1976;36:387–391
  36. Mandybur TI, Ormsby I, Zemlan FP. Cerebral aging: a quantitative study of gliosis in old nude mice. Acta Neuropathol. (Berl). 1989;77:507–513
  37. Marighetto A, Etchamendy N, Touzani K, Torrea CC, Yee BK, Rawlins JN, et al. Knowing which and knowing what: a potential mouse model for age-related human declarative memory decline. Eur. J. Neurosci. 1999;11:3312–3322
  38. Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 2005;29:913–947
  39. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006;26:4752–4762
  40. Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puolivali J, Soininen H, et al. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J. Chem. Neuroanat. 2005;30:105–118
  41. Mingaud, F., Mormede, C., Pallet, V., Jaffard, R., Higueret, P., Marighetto, A., 2005. Beneficial effects of vitamin A enriched diet on working memory in aged mice. SfN abstract, No. 199/20.
  42. Morimura T, Hattori M, Ogawa M, Mikoshiba K. Disabled1 regulates the intracellular trafficking of reelin receptors. J. Biol. Chem. 2005;280:16901–16908
  43. Mormede, C., Mons, N., Jaffard, R., Marighetto, A., 2006. Functional alterations in prefronto-hippocampal circuits in a mouse model of aging-related decline in short-term memory. SfN abstract, No. 812/13.
  44. Motoi Y, Itaya M, Mori H, Mizuno Y, Iwasaki T, Hattori H, et al. Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neurosci. Lett. 2004;368:144–147
  45. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I. Maternal immune activation during pregnancy increases limbic GABA(A) receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience. 2006;143:51–62
  46. Nyffeler M, Zhang WN, Feldon J, Knuesel I. Differential expression of PSD proteins in age-related spatial learning impairments. Neurobiol. Aging. 2007;28:143–155
  47. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 2004;43:321–332
  48. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409–421
  49. Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, et al. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J. 2003;17:295–297
  50. Pesold C, Impagnatiello F, Pisu MG, Uzunov DP, Costa E, Guidotti A, et al. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. U.S.A. 1998;95:3221–3226
  51. Potier B, Krzywkowski P, Lamour Y, Dutar P. Loss of calbindin-immunoreactivity in CA1 hippocampal stratum radiatum and stratum lacunosum-moleculare interneurons in the aged rat. Brain Res. 1994;661:181–188
  52. Pryce CR, Feldon J, Fuchs E, Knuesel I, Oertle T, Sengstag C, et al. Postnatal ontogeny of hippocampal expression of the mineralocorticoid and glucocorticoid receptors in the common marmoset monkey. Eur. J. Neurosci. 2005;21:1521–1535
  53. Qiu S, Korwek KM, Pratt-Davis AR, Peters M, Bergman MY, Weeber EJ. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol. Learn. Mem. 2006;85:228–242
  54. Quattrocchi CC, Wannenes F, Persico AM, Ciafre SA, D’Arcangelo G, Farace MG, et al. Reelin is a serine protease of the extracellular matrix. J. Biol. Chem. 2002;277:303–309
  55. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U.S.A. 1998;95:10914–10919
  56. Ramos B, Baglietto-Vargas D, del Rio JC, Moreno-Gonzalez I, Santa-Maria C, Jimenez S, et al. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiol. Aging. 2006;27:1658–1672
  57. Ramos-Moreno T, Galazo MJ, Porrero C, Martinez-Cerdeno V, Clasca F. Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur. J. Neurosci. 2006;23:401–422
  58. Rice DS, Curran T. Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 2001;24:1005–1039
  59. Riedel A, Miettinen R, Stieler J, Mikkonen M, Alafuzoff I, Soininen H, et al. Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol. (Berl). 2003;106:291–302
  60. Rowan MJ, Klyubin I, Wang Q, Anwyl R. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem. Soc. Trans. 2005;33:563–567
  61. Saez-Valero J, Costell M, Sjogren M, Andreasen N, Blennow K, Luque JM. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J. Neurosci. Res. 2003;72:132–136
  62. Sarter M, Bruno JP. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol. Aging. 2004;25:1127–1139
  63. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993;90:9649–9653
  64. Shetty AK, Turner DA. Hippocampal interneurons expressing glutamic acid decarboxylase and calcium-binding proteins decrease with aging in Fischer 344 rats. J. Comp. Neurol. 1998;394:252–269
  65. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 1998;95:6460–6464
  66. Small SA, Nava AS, Perera GM, Delapaz R, Stern Y. Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging. Microsc. Res. Technol. 2000;51:101–108
  67. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 1999;97:689–701
  68. Vazquez LE, Chen HJ, Sokolova I, Knuesel I, Kennedy MB. SynGAP regulates spine formation. J. Neurosci. 2004;24:8862–8872
  69. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535–539
  70. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, et al. Soluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 2002;924:133–140
  71. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 2002;277:39944–39952
  72. Wirths O, Multhaup G, Bayer TA. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide—the first step of a fatal cascade. J. Neurochem. 2004;91:513–520
  73. Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, et al. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 2001;316:145–148
  74. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006;12:1005–1015

PII: S0197-4580(07)00338-7

doi: 10.1016/j.neurobiolaging.2007.08.011

Neurobiology of Aging
Volume 30, Issue 5 , Pages 697-716 , May 2009

Article Tools

* Image Usage & Resolution